YES, because we are in a pandemic, some tests are approved for dual sampling, and risk-benefit analysis supports it
6/n
@FDA and @GovCanHealth approved RATs for the original strain, but this is a different disease that spreads uncontrollably and follows a different dynamic.
If throat tongue sampling for RATs were to lead to false positives or negatives, it would already have been relayed and amplified on twitter.
Knowing RAT kits, and the comparatively large buffer volumes, we expect them to work.
9/n
Nose swabbing only means high risk of false negative test and of spreading omicron = high risk. Any benefit?
The added benefit of detecting cases thanks to throat and tongue swabbing (and nose swabbing) is large, while the risk of compromising the tests is low.
10/n
CONCLUSION: Rapid tests work with #omicron, but swab tonsils and tongue before swabbing the two nostrils on two consecutive days (if negative on first day) as @Bob_Wachter explains it:
Regulatory approval logic commands us to not use the BTNX test shown in the image 👆 because it is not approved for self-testing, nor for asymptomatic testing, as of today. 👇
Yet it is widely distributed and used for self-testing 🤔 2/n
2 years into the pandemic, brainless omicron is again exposing our failure to operate based on intelligence - in the military sense - and make quick decisions based on incomplete information.
By requiring certainty, maybe the only certainty is that it will be too late.
3/n